ROYCE & ASSOCIATES LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$21,000
+90.9%
1,425
+113.6%
0.00%
Q2 2018$11,000
+57.1%
667
+106.5%
0.00%
Q1 2018$7,0003230.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders